Kezar Life Sciences has become the latest biotech to decide that it could do better than a buyout offer from Concentra Biosciences. Concentra’s parent company Tang Capital Partners has a track ...
ADDISON, Texas--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation’s leader in occupational medicine, today announced the opening of a new medical center in Chattanooga, Tennessee. The medical ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
(RTTNews) - Kezar Life Sciences (KZR) announced that its Board has rejected the unsolicited, non-binding proposal from Concentra Biosciences, to acquire all of the outstanding shares of common ...
Earlier on Thursday, Kezar Life Sciences rejected the previously disclosed unsolicited, non-binding proposal from Concentra Biosciences for cash consideration of $1.10 per share, plus a contingent ...
1 Day CON -2.54% DJIA 0.37% S&P Mid Cap 400 0.15% Health Care/Life Sciences -0.15% ...
ADDISON, Texas, October 07, 2024--Concentra® (NYSE: CON), the nation’s leader in occupational medicine, today announced the opening of a new medical center in Orlando, Florida. The medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback